KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $2.90 $4.87 Friday, 27th Jan 2023 CLBS stock ended at $3.55. This is 1.14% more than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 1.43% from a day low at $3.50 to a day high of $3.55.
90 days $2.90 $4.87
52 weeks $0.402 $9.75

Historical Caladrius Biosciences prices

Date Open High Low Close Volume
Feb 17, 2016 $5.20 $5.80 $5.20 $5.60 13 390
Feb 16, 2016 $5.00 $5.30 $5.00 $5.20 10 150
Feb 12, 2016 $5.00 $5.10 $4.70 $5.00 4 490
Feb 11, 2016 $5.00 $5.00 $4.50 $4.80 8 480
Feb 10, 2016 $5.00 $5.50 $4.90 $4.90 17 390
Feb 09, 2016 $5.30 $5.60 $4.90 $5.10 9 470
Feb 08, 2016 $5.50 $5.50 $5.00 $5.10 11 260
Feb 05, 2016 $5.30 $5.60 $5.20 $5.50 18 130
Feb 04, 2016 $5.20 $5.50 $5.20 $5.30 4 340
Feb 03, 2016 $5.20 $5.60 $5.20 $5.20 3 670
Feb 02, 2016 $5.30 $5.50 $5.00 $5.30 4 990
Feb 01, 2016 $5.50 $5.90 $5.00 $5.30 15 290
Jan 29, 2016 $5.70 $6.00 $4.90 $5.50 34 770
Jan 28, 2016 $6.10 $6.10 $5.50 $5.60 9 720
Jan 27, 2016 $6.00 $6.20 $5.50 $5.60 25 350
Jan 26, 2016 $6.00 $6.40 $5.80 $6.10 12 660
Jan 25, 2016 $6.40 $6.60 $6.30 $6.30 11 060
Jan 22, 2016 $6.40 $6.50 $5.80 $6.30 18 030
Jan 21, 2016 $5.80 $6.50 $5.80 $6.20 12 530
Jan 20, 2016 $6.00 $6.40 $5.50 $5.80 24 360
Jan 19, 2016 $6.50 $7.00 $5.80 $6.40 14 960
Jan 15, 2016 $6.40 $6.60 $6.00 $6.50 23 810
Jan 14, 2016 $5.50 $6.50 $5.30 $6.50 34 580
Jan 13, 2016 $5.30 $5.60 $5.10 $5.50 19 830
Jan 12, 2016 $5.30 $5.80 $5.10 $5.30 28 830
Click to get the best stock tips daily for free!

About Caladrius Biosciences

Caladrius Biosciences Caladrius Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing cellular therapies to reverse disease and/or promote the regeneration of damaged tissue. Its product candidates include HONEDRA, a recipient of SAKIGAKE designation that is in Phase II clinical trial for the treatment of critical limb ischemia; XOWNA that is in Phase IIb clinical trial for the treatment of coronary microvascular dysf... CLBS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT